ETFDH
From Wikipedia, the free encyclopedia
|
Electron-transferring-flavoprotein dehydrogenase
|
||||||||||||||
| PDB rendering based on 2gmh. | ||||||||||||||
| Available structures: 2gmh, 2gmj | ||||||||||||||
| Identifiers | ||||||||||||||
| Symbol(s) | ETFDH; MADD; ETFQO | |||||||||||||
| External IDs | OMIM: 231675 MGI: 106100 HomoloGene: 3275 | |||||||||||||
|
||||||||||||||
| RNA expression pattern | ||||||||||||||
| Orthologs | ||||||||||||||
| Human | Mouse | |||||||||||||
| Entrez | 2110 | 66841 | ||||||||||||
| Ensembl | ENSG00000171503 | ENSMUSG00000027809 | ||||||||||||
| Uniprot | Q16134 | Q6PF96 | ||||||||||||
| Refseq | NM_004453 (mRNA) NP_004444 (protein) |
NM_025794 (mRNA) NP_080070 (protein) |
||||||||||||
| Location | Chr 4: 159.81 - 159.85 Mb | Chr 3: 79.69 - 79.71 Mb | ||||||||||||
| Pubmed search | [1] | [2] | ||||||||||||
Electron-transferring-flavoprotein dehydrogenase, also known as ETFDH, is a human gene.[1]
Electron-transferring-flavoprotein dehydrogenase in the inner mitochondrial membrane accepts electrons from electron-transfer flavoprotein which is located in the mitochondrial matrix and reduces ubiquinone in the mitochondrial membrane. The protein is synthesized as a 67-kDa precursor which is targeted to mitochondria and processed in a single step to a 64-kDa mature form located in the mitochondrial membrane. Deficiency in electron-transferring-flavoprotein dehydrogenase have been demonstrated in some patients with type II glutaricacidemia.[1]
[edit] References
[edit] Further reading
- Olsen RK, Olpin SE, Andresen BS, et al. (2007). "ETFDH mutations as a major cause of riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency.". Brain 130 (Pt 8): 2045–54. doi:. PMID 17584774.
- Gempel K, Topaloglu H, Talim B, et al. (2007). "The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electron-transferring-flavoprotein dehydrogenase (ETFDH) gene.". Brain 130 (Pt 8): 2037–44. doi:. PMID 17412732.
- Kimura K, Wakamatsu A, Suzuki Y, et al. (2006). "Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.". Genome Res. 16 (1): 55–65. doi:. PMID 16344560.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121–7. doi:. PMID 15489334.
- Olsen RK, Andresen BS, Christensen E, et al. (2003). "Clear relationship between ETF/ETFDH genotype and phenotype in patients with multiple acyl-CoA dehydrogenation deficiency.". Hum. Mutat. 22 (1): 12–23. doi:. PMID 12815589.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:. PMID 12477932.
- Goodman SI, Binard RJ, Woontner MR, Frerman FE (2003). "Glutaric acidemia type II: gene structure and mutations of the electron transfer flavoprotein:ubiquinone oxidoreductase (ETF:QO) gene.". Mol. Genet. Metab. 77 (1-2): 86–90. PMID 12359134.
- Simkovic M, Degala GD, Eaton SS, Frerman FE (2002). "Expression of human electron transfer flavoprotein-ubiquinone oxidoreductase from a baculovirus vector: kinetic and spectral characterization of the human protein.". Biochem. J. 364 (Pt 3): 659–67. doi:. PMID 12049629.
- White RA, Dowler LL, Angeloni SV, Koeller DM (1996). "Assignment of Etfdh, Etfb, and Etfa to chromosomes 3, 7, and 13: the mouse homologs of genes responsible for glutaric acidemia type II in human.". Genomics 33 (1): 131–4. doi:. PMID 8617498.
- Goodman SI, Axtell KM, Bindoff LA, et al. (1994). "Molecular cloning and expression of a cDNA encoding human electron transfer flavoprotein-ubiquinone oxidoreductase.". Eur. J. Biochem. 219 (1-2): 277–86. PMID 8306995.

